These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


179 related items for PubMed ID: 24961874

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Antiangiogenic and antitumor activities of peptide inhibiting the vascular endothelial growth factor binding to neuropilin-1.
    Starzec A, Vassy R, Martin A, Lecouvey M, Di Benedetto M, Crépin M, Perret GY.
    Life Sci; 2006 Nov 17; 79(25):2370-81. PubMed ID: 16959272
    [Abstract] [Full Text] [Related]

  • 4. VEGF-A165 induces human aortic smooth muscle cell migration by activating neuropilin-1-VEGFR1-PI3K axis.
    Banerjee S, Mehta S, Haque I, Sengupta K, Dhar K, Kambhampati S, Van Veldhuizen PJ, Banerjee SK.
    Biochemistry; 2008 Mar 18; 47(11):3345-51. PubMed ID: 18284215
    [Abstract] [Full Text] [Related]

  • 5. Expression of the vascular endothelial growth factor receptor neuropilin-1 in the human endometrium.
    Hess AP, Schanz A, Baston-Buest DM, Hirchenhain J, Stoff-Khalili MA, Bielfeld P, Kruessel JS.
    J Reprod Immunol; 2009 Jan 18; 79(2):129-36. PubMed ID: 18996601
    [Abstract] [Full Text] [Related]

  • 6. Molecular modelling, synthesis and biological evaluation of peptide inhibitors as anti-angiogenic agent targeting neuropilin-1 for anticancer application.
    Kamarulzaman EE, Vanderesse R, Gazzali AM, Barberi-Heyob M, Boura C, Frochot C, Shawkataly O, Aubry A, Wahab HA.
    J Biomol Struct Dyn; 2017 Jan 18; 35(1):26-45. PubMed ID: 26766582
    [Abstract] [Full Text] [Related]

  • 7. Design, synthesis and in vitro biological evaluation of a small cyclic peptide as inhibitor of vascular endothelial growth factor binding to neuropilin-1.
    Grabowska K, Puszko AK, Lipiński PFJ, Laskowska AK, Wileńska B, Witkowska E, Misicka A.
    Bioorg Med Chem Lett; 2016 Jun 15; 26(12):2843-2846. PubMed ID: 27142754
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Structure-activity relationship study of a small cyclic peptide H-c[Lys-Pro-Glu]-Arg-OH: a potent inhibitor of Vascular Endothelial Growth Factor interaction with Neuropilin-1.
    Grabowska K, Puszko AK, Lipiński PF, Laskowska AK, Wileńska B, Witkowska E, Perret GY, Misicka A.
    Bioorg Med Chem; 2017 Jan 15; 25(2):597-602. PubMed ID: 27889287
    [Abstract] [Full Text] [Related]

  • 16. Synergistic Binding of Vascular Endothelial Growth Factor-A and Its Receptors to Heparin Selectively Modulates Complex Affinity.
    Teran M, Nugent MA.
    J Biol Chem; 2015 Jun 26; 290(26):16451-62. PubMed ID: 25979342
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Relative effects of VEGF-A and VEGF-C on endothelial cell proliferation, migration and PAF synthesis: Role of neuropilin-1.
    Bernatchez PN, Rollin S, Soker S, Sirois MG.
    J Cell Biochem; 2002 Jun 26; 85(3):629-39. PubMed ID: 11968003
    [Abstract] [Full Text] [Related]

  • 20. Mechanism of selective VEGF-A binding by neuropilin-1 reveals a basis for specific ligand inhibition.
    Parker MW, Xu P, Guo HF, Vander Kooi CW.
    PLoS One; 2012 Jun 26; 7(11):e49177. PubMed ID: 23145112
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.